These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7492755)

  • 1. Generation of a human monoclonal antibody to hepatitis C virus, JRA1 by activation of peripheral blood lymphocytes and hypo-osmolar electrofusion.
    Zimmermann U; Love-Homan L; Gessner P; Clark D; Klöck G; Johlin FC; Neil GA
    Hum Antibodies Hybridomas; 1995; 6(2):77-80. PubMed ID: 7492755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro stimulation of human peripheral blood B cells from normal individuals by activated T cells increases the efficiency of hybridoma generation.
    Ferraro AS; Newkirk MM
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):80-5. PubMed ID: 8100151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High efficiency creation of human monoclonal antibody-producing hybridomas.
    Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
    J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.
    Cerino A; Boender P; La Monica N; Rosa C; Habets W; Mondelli MU
    J Immunol; 1993 Dec; 151(12):7005-15. PubMed ID: 7505020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient electric field-induced generation of hybridomas from human B lymphocytes without prior activation in vitro.
    Kwekkeboom J; de Groot C; Tager JM
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):48-53. PubMed ID: 1576322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscale production of hybridomas by hypo-osmolar electrofusion.
    Zimmermann U; Klöck G; Gessner P; Sammons DW; Neil GA
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):14-8. PubMed ID: 1576318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of B-lymphocyte differentiation in patients infected with hepatitis C virus.
    Fournillier A; Freida D; Defrance T; Merle P; Trépo C; Inchauspé G
    J Med Virol; 2004 Apr; 72(4):566-74. PubMed ID: 14981759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human hybridoma generation by hypo-osmolar electrofusion: characterization of human monoclonal antibodies to Schistosoma mansoni parasite antigens.
    Klock G; Wisnewski AV; el-Bassiouni EA; Ramadan MI; Gessner P; Zimmermann U; Kresina TF
    Hybridoma; 1992 Aug; 11(4):469-81. PubMed ID: 1398684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of human monoclonal antibody after fusion of an immortal T cell line and lymphocytes from the peripheral blood of a patient with colon carcinoma.
    Dillman SL; Aldenderfer P; Strelkauskas A
    Hum Antibodies Hybridomas; 1994; 5(1-2):32-40. PubMed ID: 7858181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary immunisation of hepatitis C virus (HCV)-specific antibody producing B cells by lipidated peptides.
    Langhans B; Braunschweiger I; Schweitzer S; Sauerbruch T; Spengler U
    Vaccine; 2004 Mar; 22(11-12):1441-7. PubMed ID: 15063567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
    Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
    Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C.
    Umemura T; Wang RY; Schechterly C; Shih JW; Kiyosawa K; Alter HJ
    Hepatology; 2006 Jan; 43(1):91-9. PubMed ID: 16323211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of T cell counterparts in the fusion partners for generation of human monoclonal antibodies from Staphylococcus aureus stimulated B lymphocytes.
    Gore MM; Singhania SS; Basu A; Banerjee K
    Hum Antibodies; 1997; 8(1):26-32. PubMed ID: 9265502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
    Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
    Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
    Vardas E; Sitas F; Seidel K; Casteling A; Sim J
    Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of CD8+ T lymphocytes by murine monoclonal CD8 antibodies and restored specific T cell proliferation in vivo in a patient with chronic hepatitis C.
    Kiefersauer S; Reiter C; Eisenburg J; Diepolder HM; Rieber EP; Riethmüller G; Gruber R
    J Immunol; 1997 Oct; 159(8):4064-71. PubMed ID: 9378996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection.
    Rico MA; Ruiz S; Subirá D; Barril G; Cigarrán S; Castañón S; Quiroga JA; Selgas R; Carreño V
    J Med Virol; 2004 Jan; 72(1):66-74. PubMed ID: 14635013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
    Perkins S; Foung SK
    Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.
    Penna A; Missale G; Lamonaca V; Pilli M; Mori C; Zanelli P; Cavalli A; Elia G; Ferrari C
    Hepatology; 2002 May; 35(5):1225-36. PubMed ID: 11981773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.